Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery

Neurology
Tracey A MilliganEdward B Bromfield

Abstract

Antiepileptic drugs are routinely given after craniotomy. Though phenytoin (PHT) is still the most commonly used agent, levetiracetam (LEV) is increasingly administered for this purpose. This retrospective study compared the use of LEV and PHT as monotherapy prophylaxis following supratentorial neurosurgery. Patients receiving LEV monotherapy after supratentorial craniotomy were reviewed and compared to a control group of patients receiving PHT monotherapy. One of 105 patients taking LEV and 9/210 patients taking PHT had seizures within 7 days of surgery (p = 0.17). Adverse drug reactions requiring change in therapy during hospitalization occurred in 1/105 patients taking LEV and 38/210 patients taking PHT (p < 0.001). Among patients followed for at least 12 months, 11/42 (26%) treated with LEV vs 42/117 (36%) treated with PHT developed epilepsy (p = 0.34); 64% remained on LEV, while 26% remained on PHT (p = 0.03). Both levetiracetam (LEV) and phenytoin (PHT) were associated with a low risk of early postoperative seizures and a moderate risk of later epilepsy. LEV was associated with significantly fewer early adverse reactions than PHT and with a higher retention rate in patients who were followed for at least 1 year and develo...Continue Reading

Citations

Feb 11, 2010·Journal of Neuro-oncology·Justin B UseryChristopher K Finch
Apr 29, 2010·Current Neurology and Neuroscience Reports·Edward K Avila, Jerome Graber
Jun 16, 2009·Current Treatment Options in Neurology·Barbara S Koppel
May 11, 2011·Current Treatment Options in Neurology·Amy A Pruitt
Oct 24, 2008·The New England Journal of Medicine·Jong Woo LeeSantosh Kesari
Dec 16, 2011·Brain : a Journal of Neurology·Marjolein de GrootJan J Heimans
Nov 1, 2012·Neuro-oncology·Roberta RudàRiccardo Soffietti
Aug 14, 2010·Current Opinion in Oncology·Roberta RudàRiccardo Soffietti
May 31, 2012·BMC Neurology·Syed Nabeel ZafarMuhammad Shahzad Shamim
Nov 30, 2013·Journal of Neurosurgery. Pediatrics·Seema BansalJessica L Carpenter
Feb 20, 2014·Asian Journal of Neurosurgery·Sankalp GokhaleDavid L McDonagh
Mar 29, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Rafal M KaminskiHenrik Klitgaard
Apr 25, 2014·Neurosurgical Review·R BauerI Unterberger
Oct 4, 2014·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Seema BansalJessica L Carpenter
Apr 26, 2011·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Benjamin W Y LoMaureen O Meade
Aug 25, 2010·Current Opinion in Neurology·Andrea O Rossetti, Roger Stupp
May 10, 2013·Expert Review of Clinical Pharmacology·Jordi BrunaRoser Velasco
May 18, 2010·Expert Review of Anticancer Therapy·Charles J Vecht, Erik B Wilms
Mar 25, 2016·Annals of Indian Academy of Neurology·Faruk IncecikSakir Altunbasak
Jun 28, 2012·Revista da Associação Médica Brasileira·Eduardo Mekitarian FilhoSérgio Cavalheiro
Sep 25, 2012·Annales Françaises D'anesthèsie Et De Rèanimation·N Engrand, D Osinski
Dec 3, 2011·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·K KernM Lange
Mar 5, 2016·Neurologia Medico-chirurgica·Ryosuke Hanaya, Kazunori Arita
Nov 28, 2013·Pharmacotherapy·A Shaun RoweUNKNOWN Neurocritical Care Society Pharmacy Section
Jun 9, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Yang YuanLuo Jiewen
Jul 15, 2015·Acta neurochirurgica·Hai XueTiit Mathiesen
Oct 30, 2009·Seizure : the Journal of the British Epilepsy Association·Dharmen Shah, Aatif M Husain
May 4, 2013·Seizure : the Journal of the British Epilepsy Association·Shraddha SrinivasanJong Woo Lee
Jun 23, 2012·Seizure : the Journal of the British Epilepsy Association·A McTagueR Appleton
Jul 21, 2015·Journal of Neurosurgical Anesthesiology·David TurnbullCharles Reilly
Mar 8, 2016·British Journal of Clinical Pharmacology·Chryssa PourzitakiEkaterini Amaniti
Oct 26, 2016·CNS Drugs·Wolfgang LöscherHenrik Klitgaard
Oct 9, 2016·Anaesthesia Critical Care & Pain Medicine·Laurent LonjaretThomas Geeraerts

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.